PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Infection and Immunity, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.\', \'Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.\', \'Southern Marine Science and Engineering Guangdong Laboratory, Zhuhai 519000, China.\', \'Department of Clinical Laboratory, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People\'s Hospital, Qingyuan 511518, China.\', \'Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.\', \'Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acsami.1c02755
?:hasPublicationType
?:journal
  • ACS applied materials & interfaces
is ?:pmid of
?:pmid
?:pmid
  • 33930273
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.784
?:rankingScore_hIndex
  • 143
is ?:relation_isRelatedTo_publication of
?:title
  • Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all